Example: Heart Attack

Search clinical trials for: Raltitrexed

Total 45 results

NCT04241731

Recruiting

A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT04103398

Not yet recruiting

TACE Plus Sorafenib Versus TACE Alone for Recurrent Unresectable Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma; Sorafenib; Transarterial Chemoembolization
NCT03823079

Not yet recruiting

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Conditions: Recurrent Colorectal Carcinoma; Thrombopenia
NCT03813641

Recruiting

RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)

Conditions: Colorectal Cancer
NCT03811652

Completed

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Conditions: Non Small Cell Lung Cancer Squamous (NSCLC-Sq); Head and Neck Squamous Cell Carcinoma (HNSCC); Small Cell Lung Cancer (SCLC); Pancreatic Ductal Adenocarcinoma (PDAC); Colorectal Cancer (CRC); Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT03585530

Recruiting

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

Conditions: Esophagus Squamous Cell Carcinoma
NCT03398512

Terminated

HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer

Conditions: Peritoneal Metastases From Colorectal Cancer
NCT03392103

Unknown status

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Conditions: Gastric Cancer
NCT03344614

Unknown status

A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT03196843

Recruiting

Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.

Conditions: Head and Neck Squamous Cell Carcinoma
NCT03179579

Not yet recruiting

Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer

Conditions: Gastric Cancer; Peritoneal Carcinomatosis
NCT03126071

Unknown status

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Conditions: Advanced Colorectal Cancer
NCT03083613

Unknown status

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Conditions: Gastric Cancer; Gastroesophageal Junction Adenocarcinoma
NCT03053167

Recruiting

Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

Conditions: ColoRectal Cancer
NCT02992886

Recruiting

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Conditions: Rectal Neoplasms Malignant
NCT02965248

Recruiting

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Conditions: Locally Advanced Colorectal Cancer
NCT02821559

Completed

Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer

Conditions: Metastatic Colorectal Cancer
NCT02723253

Completed

Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer

Conditions: Rectal Neoplasms
NCT02678806

Recruiting

Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion

Conditions: HepatoCellular Carcinoma
NCT02631564

Unknown status

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Conditions: Colon Cancer Liver Metastasis
NCT02618356

Unknown status

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

Conditions: Metastatic Colon Cancer
NCT02562599

Unknown status

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Conditions: Nasopharyngeal Carcinoma
NCT02557490

Unknown status

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

Conditions: Colon Cancer Liver Metastasis
NCT02485548

Unknown status

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer
NCT02453490

Unknown status

Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis

Conditions: Colorectal Cancer; Liver Metastasis
NCT02376452

Unknown status

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

Conditions: Colorectal Carcinoma
NCT02072317

Unknown status

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Conditions: Advanced Gastric Cancer
NCT01959061

Unknown status

Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

Conditions: Colorectal Cancer Metastatic
NCT01836120

Unknown status

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

Conditions: Gastric Cancer
NCT01732380

Unknown status

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

Conditions: Inoperable Esophageal Cancer Stage I-III
NCT01703910

Completed

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Conditions: Adenocarcinoma of Colon; Adenocarcinoma of Rectum; Metastatic Disease
NCT01532804

Terminated

2nd-line Treatment of Metastatic Colorectal Cancer

Conditions: Metastatic Colorectal Cancer
NCT01481545

Unknown status

Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer

Conditions: Rectal Cancer
NCT01348412

Completed

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Conditions: Colorectal Cancer; Liver Metastases
NCT00797719

Recruiting

Short Neoadjuvant Hemithoracic IMRT for MPM

Conditions: Malignant Pleural Mesothelioma
NCT00590278

Completed

A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

Conditions: Inoperable or Recurrent Rectal Cancer
NCT00234429

Completed

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Conditions: Colorectal Cancer
NCT00003109

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT00002902

Completed

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT00002893

Unknown status

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT00004254

Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Conditions: Malignant Mesothelioma
NCT00003528

Completed

Raltitrexed in Treating Children With Refractory Acute Leukemia

Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia
NCT00002828

Completed

Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT00004920

Completed

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Conditions: Malignant Mesothelioma
NCT00001341

Completed

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Conditions: Neoplasm